Hu, Xubo 胡旭波
Supervisory
| Organisation | Position | From | Until | ||
|---|---|---|---|---|---|
| 1 | * | Hangzhou Tigermed Consulting Co., Ltd. | SupervisorSupervisor | 2018-04-20 |
Main board
| Organisation | Position | From | Until | Total Return |
CAGR total return |
CAGR relative return |
||
|---|---|---|---|---|---|---|---|---|
| 1 | Amoy Diagnostics Co., Ltd. | DirDirector | 2015-06 | 2021-08 | ||||
| 2 | * | Antengene Corporation Limited | NEDNon-Executive Director | 2018-11-22 | 2021-03-26 | -8.10% | ||
| 3 | APT Medical Inc. | DirDirector | 2014-05 | |||||
| 4 | * | BBI Life Sciences Corporation | NEDNon-Executive Director | 2014-01-16 | 2018-04-20 | 89.14% | 21.27% | 8.72% |
| 5 | * | MedSci Healthcare Holdings Limited | NEDNon-Executive Director | 2021-11 | -70.33% | -69.66% | -68.68% | |
| 6 | * | MicroTech Medical (Hangzhou) Co., Ltd. | NEDNon-Executive Director | 2016-11-01 | 2023-12-27 | -79.18% | -51.20% | -42.47% |
| 7 | Shanghai Sanyou Medical Co., Ltd. | DirDirector | 2014-05 | |||||
| Average | -33.20% | -34.15% |
Some data are hidden to fit your display. Rotate?
Total returns are measured from the latest of the start date, the appointment date and 3-Jan-1994 until the earliest of the end date, the resignation/removal date and the last trading date. CAGR is the annualised return and is not shown for periods under 180 days. Relative returns are to the Tracker Fund of HK (2800), starting from the latest of 12-Nov-1999, the appointment date and the chosen start date.
* = is or was HK primary-listed
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy